Navigation Links
Biomoda to Present Paper on Enhanced Technology for Early Detection of Lung Cancer at Annual SWARM Meeting
Date:4/10/2008

Company seeks to collaborate on latest research technologies

ALBUQUERQUE, N.M., April 10 /PRNewswire-FirstCall/ -- Researchers and executives from Biomoda, Inc. (OTC Bulletin Board: BMOD) (http://www.biomoda.com), a development stage medical diagnostics company, will present a paper entitled "New Non-Invasive Technology for the Early Detection of Cancer at the Cellular Level" at the 83rd Annual Multidisciplinary Meeting of the American Association for the Advancement of Science (AAAS) Southwestern and Rocky Mountain (SWARM) Division, Thursday, April 10, in Albuquerque.

The paper will focus on Biomoda's non-invasive and cost-efficient screening technology for early detection of lung cancer. The technology, which was developed at Los Alamos National Laboratory, is based on a patented porphyrin molecule that preferentially binds to cancerous or aberrant cells extracted from the body as sputum, blood or urine. Cancerous or aberrant cells that bind porphyrin glow red under ultraviolet light; non-cancerous cells do not fluoresce.

Current diagnostic methods for lung cancer -- the leading cause of cancer-related deaths in the United States -- often detect the disease only at more advanced stages.

"This conference is an excellent venue for Biomoda to foster communication and share our research among other scientists and engineers," said John Cousins, Biomoda President. "We are excited about the opportunity to increase public understanding of our latest advances in in-vitro diagnostics for non-invasive testing for cancer at the cellular level."

Biomoda is seeking international partners interested in collaborating in the development and use of its non-invasive early-stage cancer detection technology.

Biomoda and the New Mexico Institute of Mining and Technology (New Mexico Tech) recently announced their partnership with the New Mexico Department of Veterans Services (DVS) to conduct a $350,000 clinical study using Biomoda's proprietary testing technology for detection of early lung cancer in the state's veterans. Biomoda will conduct the first year of the clinical program, while New Mexico Tech and DVS will oversee the study and provide treatment to those veterans who test positive for lung cancer.

The New Mexico state legislature recently allocated an additional $1.3 million in funding through the Interim Tobacco Settlement Committee to the clinical screening program.

Biomoda presenters at the SWARM conference include: Cousins; Leo S. Gomez, Ph.D., Director of Research; Constance J. Dorian, Director of Technical Operations; and Stephen M. Gomez, Ph.D., Senior Research Specialist.

For more information contact: John Cousins

Biomoda, Inc.

505-821-0875

verrityg@biomoda.com


'/>"/>
SOURCE Biomoda, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Arpida Invited to Present Data on Iclaprim at Scientific Conference
2. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
3. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
4. ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India
5. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting
6. Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
7. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
8. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
9. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
10. VIRxSYS Presents Data on HIV Vaccine at Keystone HIV Vaccine Symposia
11. NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... May 22, 2017  As the specialty pharmacy ... continue to make the revolutionary shift from volume-based ... for ensuring positive patient outcomes and shaping the ... shifting focus away from clinical trials and toward ... long-term specialty drug therapy utilization in precise patient ...
(Date:5/15/2017)... Enterin Inc., a privately-held CNS pharmaceutical company based ... to treat Parkinson,s disease (PD), has enrolled the first patient ... randomized, controlled, multicenter study involving patients with PD and taking ... over a 9-to-12-month period. The first stage is open label ... Participating sites include Denver , ...
(Date:5/10/2017)... , May 10, 2017 Global Health ... Latin America , published its 2017 ranking ... ranking is based on extensive data analysis from GHI,s ... largest hospitals database for the region. The GHI database covers ... , offering more than 130 data points for each institution ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... , ... “When the Stars Lead Home”: a poignant story of loss, determination, ... Weigel Douglas, an avid reader who lives in the Pacific Northwest with her husband, ... Hills Adventure Camp. She couldn’t be more grateful. , Twelve-year old Tizzy could not ...
(Date:5/26/2017)... ... May 26, 2017 , ... “Cactus Jack: Against All ... so many others. “Cactus Jack: Against All Odds” is the creation of published ... D. Hubbard is married to Jack Carlisle’s third child Jane. Walter. Walter and ...
(Date:5/24/2017)... York (PRWEB) , ... May 24, 2017 , ... Dr. ... vascular surgery in New York City. He is known for his distinguished expertise ... in vascular surgery, Dr. Benvenisty holds sub-specialty training in treating renovascular disease and ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Manju R. Kejriwal, a ... orthodontics, with or without a referral. Dr. Kejriwal understands the emotional and financial ... clear braces in Cincinnati, OH. Patients no longer need to feel the esthetic effects ...
(Date:5/24/2017)... , ... May 24, 2017 , ... ... completed Course II of the HP3 (High-Performance Periodontal Practice) continuing education (CE) series. ... the latest advancements in his field by attending numerous CE courses each year. ...
Breaking Medicine News(10 mins):